ALDX
Aldeyra Therapeutics, Inc.
3.24
USD
This page is just a preview of the data found in TrendSpider’s full version
Aldeyra Therapeutics, Inc. stock is up 16.97% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 19 Oct 15:53 | 15 Dec, 2023 | 10.00 | 248 | ||
| 20 Oct 13:47 | 15 Dec, 2023 | 5.00 | 241 |
Aldeyra Therapeutics, Inc. develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for dry eye diseases and allergic conjunctivitis.
